Servier
The Senior Manager, HEOR/RWE, Voranigo leads the strategic development and execution of Health Economics and Outcomes Research and Real-World Evidence initiatives for the Voranigo asset within a dynamic matrix organization. This role partners with cross-functional teams to drive comprehensive asset strategies, focusing on unmet medical need, disease epidemiology, and clinical and economic outcomes. The incumbent is accountable for driving clear communication of HEOR/RWE insights to ensure organizational alignment and informed decision-making.
Headquarters
Suresnes, Île-De-France, France
Company Size
10001+ employees
Founded
1954
Être libres de nos choix et dotés d’une vision à long terme sert notre vocation : engagés pour le progrès thérapeutique au bénéfice des patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Servier.
Senior Manager, Evidence & Insights (RWE & HEOR)
Real Chemistry
Senior Director, HEOR/RWE
Revolution Medicines
Director, HEOR & RWE, Europe
Revolution Medicines
Director, Field Health Economics & Outcomes Research (HEOR)
Nuvalent, Inc.
Senior Director, HEOR/RWE GI
Revolution Medicines
Associate VP - Health Economics and Outcomes Research (HEOR) - Global CMH
Eli Lilly and Company